Gene polymorphisms of biotransforming enzymes (GSTs) and their association with lung cancer in the Slovakian population

<p>Abstract</p> <p>Objective</p> <p>The aim of present study was to present the results of a case-control study focused on genetic polymorphisms of selected Phase II metabolizing enzymes (GSTM1, T1, and P1) and to investigate the association of these polymorphisms with...

Full description

Bibliographic Details
Main Authors: Matakova T, Sivonova M, Halasova E, Mistuna D, Dzian A, Berzinec P, Letkova L, Dobrota D
Format: Article
Language:English
Published: BMC 2009-12-01
Series:European Journal of Medical Research
Subjects:
Online Access:http://www.eurjmedres.com/content/14/S4/275
_version_ 1828815904272547840
author Matakova T
Sivonova M
Halasova E
Mistuna D
Dzian A
Berzinec P
Letkova L
Dobrota D
author_facet Matakova T
Sivonova M
Halasova E
Mistuna D
Dzian A
Berzinec P
Letkova L
Dobrota D
author_sort Matakova T
collection DOAJ
description <p>Abstract</p> <p>Objective</p> <p>The aim of present study was to present the results of a case-control study focused on genetic polymorphisms of selected Phase II metabolizing enzymes (GSTM1, T1, and P1) and to investigate the association of these polymorphisms with lung cancer risk in the Slovakian population.</p> <p>Material and methods</p> <p>The study encompassed 160 lung cancer cases and 220 controls. DNA was extracted from peripheral blood leukocytes, and the polymorphisms of GSTM1, GSTT1 and GSTP1 enzymes were determined by PCR-based methods. We determined the genotype distribution of all these genes and their combinations. The association between specific genotypes and the development of lung cancer were examined using logistic regression analysis to calculate odds ratios (OR) and 95% confidence intervals (CI).</p> <p>Results</p> <p>We found that the GSTM1 null genotype (OR = 1.6; 95% CI = 1.03-2.4; χ<sup>2 </sup>= 4.08, and P = 0.04) was associated with elevated risk. A significant correlation also was found for the combined genotypes of GSTM1 null and GSTP1 Ile/Val and Val/Val (OR = 2.01; 95% CI = 1.1-6.1; χ<sup>2 </sup>= 3.6, and P = 0.02) and GSTM1 null and GSTT1 positive (OR = 2.00; 95% CI = 1.2-3.2; χ<sup>2 </sup>= 7.3, and P = 0.006).</p> <p>Conclusions</p> <p>We conclude that the genotype of metabolizing enzymes and allelic combinations underscore the risk for lung cancer. Individual risk assessment may be further improved by increasing the number of polymorphisms studied and combining them with the traditional epidemiological risk factor.</p>
first_indexed 2024-12-12T10:53:23Z
format Article
id doaj.art-b14bff82abaf45e6847e0119cb7dfffb
institution Directory Open Access Journal
issn 2047-783X
language English
last_indexed 2024-12-12T10:53:23Z
publishDate 2009-12-01
publisher BMC
record_format Article
series European Journal of Medical Research
spelling doaj.art-b14bff82abaf45e6847e0119cb7dfffb2022-12-22T00:26:44ZengBMCEuropean Journal of Medical Research2047-783X2009-12-0114Suppl 427527910.1186/2047-783X-14-S4-275Gene polymorphisms of biotransforming enzymes (GSTs) and their association with lung cancer in the Slovakian populationMatakova TSivonova MHalasova EMistuna DDzian ABerzinec PLetkova LDobrota D<p>Abstract</p> <p>Objective</p> <p>The aim of present study was to present the results of a case-control study focused on genetic polymorphisms of selected Phase II metabolizing enzymes (GSTM1, T1, and P1) and to investigate the association of these polymorphisms with lung cancer risk in the Slovakian population.</p> <p>Material and methods</p> <p>The study encompassed 160 lung cancer cases and 220 controls. DNA was extracted from peripheral blood leukocytes, and the polymorphisms of GSTM1, GSTT1 and GSTP1 enzymes were determined by PCR-based methods. We determined the genotype distribution of all these genes and their combinations. The association between specific genotypes and the development of lung cancer were examined using logistic regression analysis to calculate odds ratios (OR) and 95% confidence intervals (CI).</p> <p>Results</p> <p>We found that the GSTM1 null genotype (OR = 1.6; 95% CI = 1.03-2.4; χ<sup>2 </sup>= 4.08, and P = 0.04) was associated with elevated risk. A significant correlation also was found for the combined genotypes of GSTM1 null and GSTP1 Ile/Val and Val/Val (OR = 2.01; 95% CI = 1.1-6.1; χ<sup>2 </sup>= 3.6, and P = 0.02) and GSTM1 null and GSTT1 positive (OR = 2.00; 95% CI = 1.2-3.2; χ<sup>2 </sup>= 7.3, and P = 0.006).</p> <p>Conclusions</p> <p>We conclude that the genotype of metabolizing enzymes and allelic combinations underscore the risk for lung cancer. Individual risk assessment may be further improved by increasing the number of polymorphisms studied and combining them with the traditional epidemiological risk factor.</p>http://www.eurjmedres.com/content/14/S4/275glutathione S-transferase T1, M1, and P1lung cancerpolymorphism
spellingShingle Matakova T
Sivonova M
Halasova E
Mistuna D
Dzian A
Berzinec P
Letkova L
Dobrota D
Gene polymorphisms of biotransforming enzymes (GSTs) and their association with lung cancer in the Slovakian population
European Journal of Medical Research
glutathione S-transferase T1, M1, and P1
lung cancer
polymorphism
title Gene polymorphisms of biotransforming enzymes (GSTs) and their association with lung cancer in the Slovakian population
title_full Gene polymorphisms of biotransforming enzymes (GSTs) and their association with lung cancer in the Slovakian population
title_fullStr Gene polymorphisms of biotransforming enzymes (GSTs) and their association with lung cancer in the Slovakian population
title_full_unstemmed Gene polymorphisms of biotransforming enzymes (GSTs) and their association with lung cancer in the Slovakian population
title_short Gene polymorphisms of biotransforming enzymes (GSTs) and their association with lung cancer in the Slovakian population
title_sort gene polymorphisms of biotransforming enzymes gsts and their association with lung cancer in the slovakian population
topic glutathione S-transferase T1, M1, and P1
lung cancer
polymorphism
url http://www.eurjmedres.com/content/14/S4/275
work_keys_str_mv AT matakovat genepolymorphismsofbiotransformingenzymesgstsandtheirassociationwithlungcancerintheslovakianpopulation
AT sivonovam genepolymorphismsofbiotransformingenzymesgstsandtheirassociationwithlungcancerintheslovakianpopulation
AT halasovae genepolymorphismsofbiotransformingenzymesgstsandtheirassociationwithlungcancerintheslovakianpopulation
AT mistunad genepolymorphismsofbiotransformingenzymesgstsandtheirassociationwithlungcancerintheslovakianpopulation
AT dziana genepolymorphismsofbiotransformingenzymesgstsandtheirassociationwithlungcancerintheslovakianpopulation
AT berzinecp genepolymorphismsofbiotransformingenzymesgstsandtheirassociationwithlungcancerintheslovakianpopulation
AT letkoval genepolymorphismsofbiotransformingenzymesgstsandtheirassociationwithlungcancerintheslovakianpopulation
AT dobrotad genepolymorphismsofbiotransformingenzymesgstsandtheirassociationwithlungcancerintheslovakianpopulation